Abyan Irzaldy, Johannes D M Otten, Lindy M Kregting, Dieuwke R Mink van der Molen, Helena M Verkooijen, Nicolien T van Ravesteyn, Eveline A M Heijnsdijk, Annemiek Doeksen, Carmen C van der Pol, Daniel J Evers, Miranda F Ernst, Ida J Korfage, Harry J de Koning, Mireille J M Broeders
PURPOSE: Breast cancer (BC) screening enables early detection of BC, which may lead to improved quality of life (QoL). We aim to compare QoL between women with a screen-detected and clinically detected BC in the Netherlands. METHODS: We used data from the 'Utrecht cohort for Multiple BREast cancer intervention studies and Long-term evaluation' (UMBRELLA) between October 2013 and March 2022. Patients were categorized as screen-detected or clinically detected. We analysed three questionnaires, namely EORTC QLQ C-30, BR23, and HADS (Hospital Anxiety and Depression Scale) completed by BC patients shortly after diagnosis (T1) and one-year after treatment (T2)...
September 17, 2024: Quality of Life Research